Nektar Therapeutics (NKTR) EPS (Diluted) (2013 - 2026)

Nektar Therapeutics (NKTR) EPS (Diluted) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Nektar Therapeutics 1.49 Bn 919.46 Mn 3.16 Mn -1.74

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.74
Dec 31, 2025 -0.02
Sep 30, 2025 -1.85
Jun 30, 2025 -2.78
Mar 31, 2025 -3.30
Dec 31, 2024 2.34
Sep 30, 2024 -2.66
Jun 30, 2024 -3.76
Mar 31, 2024 -2.83
Dec 31, 2023 -3.32
Sep 30, 2023 -3.61
Jun 30, 2023 -4.04
Mar 31, 2023 -10.88
Dec 31, 2022 1.62
Sep 30, 2022 -4.72
Jun 30, 2022 -12.77
Mar 31, 2022 -7.30
Dec 31, 2021 31.00
Sep 30, 2021 -10.57
Jun 30, 2021 -10.30